PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-1.19%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$828M
AUM Growth
+$828M
(-14%)
Cap. Flow
-$45M
Cap. Flow
% of AUM
-5.44%
Top 10 Holdings %
Top 10 Hldgs %
49.76%
Holding
264
New
28
Increased
49
Reduced
25
Closed
53
Top Buys
| 1 |
Biogen
BIIB
|
$31M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$15.5M |
| 3 |
C4 Therapeutics
CCCC
|
$14.4M |
| 4 |
Bio-Techne
TECH
|
$10.8M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
$10.7M |
Top Sells
| 1 |
Natera
NTRA
|
$22M |
| 2 |
The Beauty Health Co
SKIN
|
$14.4M |
| 3 |
DexCom
DXCM
|
$14.1M |
| 4 |
ICU Medical
ICUI
|
$13.9M |
| 5 |
LivaNova
LIVN
|
$12.9M |
Sector Composition
| 1 | Healthcare | 89.68% |
| 2 | Materials | 1.3% |
| 3 | Industrials | 0.61% |
| 4 | Consumer Discretionary | 0.26% |
| 5 | Financials | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Immunic
IMUX
$79.4M
| $7.72M | 0.25% |
+683,287
| New | +$7.72M |
|
27
Intellia Therapeutics
NTLA
$1.26B
| $7.56M | 0.25% |
104,073
+50,144
| +93% | +$3.64M |
|
28
TELA Bio
TELA
$65.4M
| $6.6M | 0.21% |
567,420
+3,300
| +0.6% | +$38.4K |
|
29
ATAI Life Sciences
ATAI
$969M
| $6.51M | 0.21% |
1,278,105
+725,324
| +131% | +$3.69M |
|
30
Evolent Health
EVH
$1.11B
| $6.46M | 0.21% |
+200,000
| New | +$6.46M |
|
31
Privia Health
PRVA
$2.84B
| $6.42M | 0.21% |
240,200
+17,707
| +8% | +$473K |
|
32
Apyx Medical
APYX
$71.9M
| $6.42M | 0.21% |
982,683
+140,100
| +17% | +$915K |
|
33
SOPHiA GENETICS
SOPH
$232M
| $6.42M | 0.21% |
+829,930
| New | +$6.42M |
|
34
Milestone Pharmaceuticals
MIST
$151M
| $6.34M | 0.21% |
987,411
+55,900
| +6% | +$359K |
|
35
Avita Medical
RCEL
$116M
| $5.72M | 0.19% |
+674,316
| New | +$5.72M |
|
36
908 Devices
MASS
$199M
| $5.63M | 0.18% |
296,288
-16,658
| -5% | -$317K |
|
37
Stereotaxis
STXS
$246M
| $5.52M | 0.18% |
1,479,292
-152,807
| -9% | -$570K |
|
38
Cooper Companies
COO
$13.3B
| $5.43M | 0.18% |
+13,000
| New | +$5.43M |
|
|
SNCE
39
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $5.38M | 0.17% |
+1,006,400
| New | +$5.38M |
|
|
RCM
40
DELISTED
R1 RCM Inc. Common Stock
RCM
| $5.04M | 0.16% |
+188,455
| New | +$5.04M |
|
41
Athira Pharma
ATHA
$15.5M
| $4.58M | 0.15% |
339,468
-134,835
| -28% | -$1.82M |
|
42
Cytek Biosciences
CTKB
$501M
| $4.58M | 0.15% |
424,577
+2,800
| +0.7% | +$30.2K |
|
43
Guardant Health
GH
$8.11B
| $4.53M | 0.15% |
68,375
-33,900
| -33% | -$2.25M |
|
44
Celldex Therapeutics
CLDX
$1.57B
| $4.52M | 0.15% |
132,571
+800
| +0.6% | +$27.2K |
|
|
NYXH
45
Nyxoah
NYXH
$220M
| $4.3M | 0.14% |
221,949
+1,326
| +0.6% | +$25.7K |
|
|
SONX
46
DELISTED
Sonendo, Inc.
SONX
| $4.1M | 0.13% |
1,023,424
+146,039
| +17% | +$586K |
|
|
GRNA
47
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $3.85M | 0.12% |
+400,000
| New | +$3.85M |
|
48
GH Research
GHRS
$870M
| $3.81M | 0.12% |
208,527
-18,900
| -8% | -$346K |
|
49
Arcutis Biotherapeutics
ARQT
$1.91B
| $3.65M | 0.12% |
189,363
+50,700
| +37% | +$976K |
|
50
Alpha Teknova
TKNO
$227M
| $3.47M | 0.11% |
251,112
+1,600
| +0.6% | +$22.1K |
|